NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
(NASDAQ: NRXP) Delayed: 4.48 --0 (-0%)
Previous Close $4.48    52 Week High
Open $4.48    52 Week Low
Day High $4.48    P/E N/A 
Day Low $4.48    EPS
Volume 16,295       

(NASDAQ: NRXP) Delayed: 4.48 --0 (-0%)
Previous Close $4.48    52 Week High
Open $4.48    52 Week Low
Day High $4.48    P/E N/A 
Day Low $4.48    EPS
Volume 16,295